Aphrodisiac and androgenic effects of the aqueous extract of the roots of Vepris afzelii on cyproterone acetate-induced hypogonadism in rat-Reference-Cited by-同舟云学术

Aphrodisiac and androgenic effects of the aqueous extract of the roots of Vepris afzelii on cyproterone acetate-induced hypogonadism in rat

Published:2024-04-29 Issue: Volume: Page:
ISSN:0955-9930
Container-title:International Journal of Impotence Research
language:en
Short-container-title:Int J Impot Res

Author:

Wankeu-Nya Modeste^ORCID,Djeumeni Ornéla Néely^ORCID,Nde Zacharie^ORCID,Tchamadeu Marie Claire^ORCID,Kengne Tomutou Inès^ORCID,Hatho Towo Dominique Hyacinthe^ORCID,Koloko Brice Landry^ORCID,Massoma Lembè Dieudonné,Dongmo Alain Bertrand,Moundipa Fewou Paul,Watcho Pierre

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41443-024-00892-9.pdf

Reference35 articles.

1. Rey RA, Grinspon RP, Gottlieb S, Pasqualini T, Knoblovits P, Aszpis S, et al. Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach. Am Soc Androl Eur Acad Androl. 2012;1:3–16.

2. Kumar P, Kumar N, Thakur DS, Thakur DS, Patidar A. Male hypogonadism: symptoms and treatment. J Adv Pharm Technol Res. 2010;1:297–301.

3. Fieldman AH, Longcope C, Derby CA, Johannes CB, Aroujo AB, Coviello AD, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87:589–98.

4. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60:762–9.

5. Ventimiglia E, Ippolito S, Capogrosso P, Pederzoli F, Cazzaniga W, Boeri L, et al. Primary, secondary and compensated hypogonadism: a novel risk stratification for infertile men. Andrology. 2017;5:505–10.